Krishna Chatterjee

Krishna Chatterjee's AcademicInfluence.com Rankings

Krishna Chatterjee

Biology

#3281

World Rank

#5036

Historical Rank

Endocrinology

#45

World Rank

#52

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Krishna Chatterjee Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Vengalil Krishna Kumar Chatterjee is a British endocrinologist. He is a professor of endocrinology in the Department of Medicine at the University of Cambridge and a fellow of Churchill College, Cambridge. He is also the director of the Cambridge Clinical Research Centre, part of the National Institute for Health Research .

(See a Problem?)

Krishna Chatterjee's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension (1999) (1351)
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors (2006) (946)
The UK10K project identifies rare variants in health and disease (2015) (926)
PPARγ and human metabolic disease (2006) (701)
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance (2010) (612)
Transcriptional Activation by Peroxisome Proliferator-activated Receptor γ Is Inhibited by Phosphorylation at a Consensus Mitogen-activated Protein Kinase Site* (1997) (588)
Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization. (2002) (546)
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. (1997) (515)
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis (1999) (440)
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. (2003) (438)
Mechanism of corepressor binding and release from nuclear hormone receptors. (1999) (428)
PPAR gamma and human metabolic disease. (2006) (408)
Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia (1998) (407)
Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. (2000) (392)
Genetics of congenital hypothyroidism (2005) (387)
Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. (2010) (382)
Evidence for Gene-Nutrient Interaction at the PPARγ Locus (2001) (357)
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis (2003) (356)
A mutation in the thyroid hormone receptor alpha gene. (2012) (341)
Primary amenorrhoea and infertility due to a mutation in the β–subunit of follicle–stimulating hormone (1993) (340)
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. (1987) (336)
Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. (2002) (299)
Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells* (2004) (270)
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. (2010) (270)
A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis* (2000) (260)
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC (2009) (250)
St John's wort, a herbal antidepressant, activates the steroid X receptor. (2000) (241)
Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. (1994) (233)
The variable clinical phenotype in thyroid hormone resistance syndrome. (1994) (225)
Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. (2006) (220)
Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. (1997) (210)
Pitfalls in the measurement and interpretation of thyroid function tests☆ (2013) (210)
The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation. (2003) (203)
An organelle-specific protein landscape identifies novel diseases and molecular mechanisms (2016) (189)
Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. (1989) (188)
Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance (2006) (187)
Retardation of post‐natal development caused by a negatively acting thyroid hormone receptor α1 (2002) (181)
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement (2012) (174)
Follitropin (FSH) Deficiency in an Infertile Male due to FSHβ Gene Mutation. A Syndrome of Normal Puberty and Virilization but Under-developed Testicles with Azoospermia, Low FSH but High Lutropin and Normal Serum Testosterone Concentrations (1998) (169)
Prospective functional classification of all possible missense variants in PPARG (2016) (167)
A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. (2002) (166)
Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. (2008) (162)
A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease (2003) (158)
Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. (1991) (158)
Evidence for gene-nutrient interaction at the PPARgamma locus. (2001) (156)
Inhibition of Cellular Proliferation through IκB Kinase-Independent and Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of Cyclin D1 (2001) (153)
Initial thyroid status and cardiovascular risk factors: The EPIC‐Norfolk prospective population study (2010) (151)
Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance (2017) (149)
The expression of thyroid hormone receptors in human bone. (1996) (149)
Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. (1994) (148)
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. (2004) (145)
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. (2009) (142)
A role for helix 3 of the TRβ ligand‐binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone (1998) (142)
Elevated plasma adiponectin in humans with genetically defective insulin receptors. (2006) (132)
Corrigendum: TCTEX1D2 mutations underlie Jeune asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport (2016) (131)
Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. (1997) (127)
PPARgamma regulates the function of human dendritic cells primarily by altering lipid metabolism. (2007) (127)
An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor α. (2013) (124)
Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone (2006) (121)
X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3 (2017) (117)
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. (2005) (113)
Arachidonic Acid Stimulates Glucose Uptake in 3T3-L1 Adipocytes by Increasing GLUT1 and GLUT4 Levels at the Plasma Membrane (2001) (111)
Functional analysis of a transactivation domain in the thyroid hormone beta receptor. (1994) (111)
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. (1997) (108)
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. (2000) (107)
PPARγ Agonists Ameliorate Endothelial Cell Activation via Inhibition of Diacylglycerol–Protein Kinase C Signaling Pathway: Role of Diacylglycerol Kinase (2004) (106)
Hypothalamic mTOR pathway mediates thyroid hormone‐induced hyperphagia in hyperthyroidism (2012) (106)
Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. (2010) (101)
Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients. (2014) (100)
Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. (2001) (96)
Digenic inheritance of severe insulin resistance in a human pedigree (2002) (96)
Recent advances in central congenital hypothyroidism (2015) (92)
Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level? (2004) (86)
HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer. (2000) (85)
A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. (2006) (83)
A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. (1998) (82)
Leptin Deficiency Unmasks the Deleterious Effects of Impaired Peroxisome Proliferator–Activated Receptor γ Function (P465L PPARγ) in Mice (2006) (82)
Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. (2012) (80)
Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. (1994) (80)
Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. (2001) (79)
Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-Situ (2016) (79)
The IGSF1 deficiency syndrome: characteristics of male and female patients. (2013) (79)
The Structural Basis for the Specificity of Retinoid-X Receptor-selective Agonists: New Insights Into the Role of Helix H12* (2002) (76)
Clonal dynamics of haematopoiesis across the human lifespan (2021) (75)
A novel missense mutation in human TTF-2 (FKHL15) gene associated with congenital hypothyroidism but not athyreosis. (2006) (73)
Resistance to thyroid hormone due to defective thyroid receptor alpha (2015) (72)
Negative and positive transcriptional regulation by thyroid hormone receptor isoforms. (1990) (70)
Development of a disease-specific quality of life questionnaire in Addison's disease. (2010) (70)
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans (2014) (69)
Dehydroepiandrosterone replacement therapy. (2001) (69)
Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. (1997) (68)
Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse. (1994) (67)
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. (2014) (65)
Digenic inheritance of severe insulin resistance in a human pedigree (2002) (64)
Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis. (2016) (64)
Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors (2009) (62)
Isolated deficiency of follicle-stimulating hormone re-revisited. (1997) (59)
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. (2004) (59)
Thyroid dyshormonogenesis is mainly caused by TPO mutations in consanguineous community (2013) (59)
Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators. (1991) (59)
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. (2006) (58)
Development of a luminescent bioassay for thyroid stimulating antibodies. (1999) (58)
Prenatal diagnosis of thyroid hormone resistance. (1999) (58)
Thyroid hormone receptors and their role in development. (1992) (58)
Thyroid surgery for Graves' disease and Graves' ophthalmopathy. (2015) (57)
Cardiac involvement in thyroid hormone resistance. (2002) (57)
Resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha. (2013) (55)
Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features (2018) (52)
Epidermal growth factor in blood (1986) (50)
Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor (2004) (50)
Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy. (2005) (49)
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. (2009) (49)
Patterns of thyroid hormone receptor expression in zebrafish and generation of a novel model of resistance to thyroid hormone action (2016) (49)
A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms. (2005) (46)
Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism (2017) (45)
Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. (1994) (45)
Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells (2005) (45)
Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity (2017) (43)
Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial. (2019) (43)
Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. (1998) (42)
Homozygous loss-of-function mutations in SLC26A7 cause goitrous congenital hypothyroidism. (2018) (42)
Resistance to thyroid hormone. (2013) (42)
Resistance to Thyroid Hormone due to Heterozygous Mutations in Thyroid Hormone Receptor Alpha. (2017) (42)
Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother. (2006) (42)
Life-threatening metabolic alkalosis in Pendred syndrome (2011) (42)
Thyroid Hormone-mediated Enhancement of Heterodimer Formation between Thyroid Hormone Receptor β and Retinoid X Receptor* (1997) (42)
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma. (2007) (40)
Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo. (1996) (39)
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. (2014) (37)
The localization of thyroid hormone receptor mRNAs in human bone. (2000) (35)
Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day‐case procedure (2004) (35)
Thyroid Hormone Resistance Syndrome (1991) (34)
Contrasting Phenotypes in Resistance to Thyroid Hormone Alpha Correlate with Divergent Properties of Thyroid Hormone Receptor α1 Mutant Proteins (2016) (33)
Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome (1992) (33)
A clinical approach to severe insulin resistance. (2007) (32)
A Pharmacogenetic Approach to the Treatment of Patients With PPARG Mutations (2018) (31)
Resistance to Thyroid Hormone α-Emerging Definition of a Disorder of Thyroid Hormone Action. (2016) (29)
A Novel Albumin Gene Mutation (R222I) in Familial Dysalbuminemic Hyperthyroxinemia (2014) (28)
Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis. (2003) (27)
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. (2020) (27)
human PPARg associated with severe insulin resistance, diabetes mellitus and hypertension (1999) (27)
Maternal isodisomy for chromosome 9 causing homozygosity for a novel FOXE1 mutation in syndromic congenital hypothyroidism. (2010) (27)
Fatty acid metabolism in patients with PPARgamma mutations. (2008) (25)
Molecular spectrum of TSHβ subunit gene defects in central hypothyroidism in the UK and Ireland (2016) (25)
Nomenclature of thyroid hormone receptor-beta gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11th July 1993, Cambridge, UK. (1994) (25)
Immunoglobulin interference in serum follicle-stimulating hormone assays: autoimmune and heterophilic antibody interference (2010) (23)
Galanin abolishes the inhibitory effect of cholinergic blockade on growth hormone-releasing hormone-induced secretion of growth hormone in man. (1988) (23)
Genetic disorders of nuclear receptors (2017) (23)
Low-frequency variation in TP53 has large effects on head circumference and intracranial volume (2018) (22)
Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor γ resistance (2001) (22)
Nomenclature of thyroid hormone receptor μ gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10–11 July 1993, Cambridge, UK (1994) (21)
A Novel Thyrotropin-Releasing Hormone Receptor Missense Mutation (P81R) in Central Congenital Hypothyroidism (2016) (20)
Steroid hormones and adipose tissue (1996) (20)
Negative regulation of the thyroid-stimulating hormone a gene by thyroid hormone : Receptor interaction adjacent to the TATA box ( glycoprotein hormones / erbA protooncogene / gene transcription / steroid receptors ) (20)
Transcriptional repression by nuclear receptors: mechanisms and role in disease. (2000) (20)
The Hypercoagulable state in Hyperthyroidism is mediated via the Thyroid Hormone β Receptor pathway. (2016) (20)
An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease (2013) (19)
Mild cold effects on hunger, food intake, satiety and skin temperature in humans (2016) (19)
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab (2018) (18)
A novel CYP11B2 gene mutation in an Asian family with aldosterone synthase deficiency. (2006) (18)
Human disorders affecting the selenocysteine incorporation pathway cause systemic selenoprotein deficiency. (2020) (18)
Interference from heterophilic antibodies in TSH assays (2009) (18)
Mutations in thyroid hormone receptor α1 cause premature neurogenesis and progenitor cell depletion in human cortical development (2019) (18)
Nuclear receptors in disease: thyroid receptor beta, peroxisome-proliferator-activated receptor gamma and orphan receptors. (2004) (17)
Classification and Proposed Nomenclature for Inherited Defects of Thyroid Hormone Action, Cell Transport, and Metabolism (2014) (16)
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience (2020) (14)
Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’ (2019) (14)
A deletion including exon 2 of the TSHR gene is associated with thyroid dysgenesis and severe congenital hypothyroidism (2014) (13)
Effect of mutations in the β1‐thyroid hormone receptor on the inhibition of T3 binding by desethylamiodarone (1999) (13)
The effect of cholinergic blockade on the growth hormone response to galanin in humans. (1988) (13)
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe. (2014) (13)
Use of adrenal arterial embolization in severe ACTH-dependent Cushing's syndrome. (1989) (13)
Anemia in Patients With Resistance to Thyroid Hormone α: A Role for Thyroid Hormone Receptor α in Human Erythropoiesis (2017) (13)
Isolation and characterisation of the retinoic acid receptor-alpha gene in the Japanese pufferfish, F. rubripes. (1999) (12)
Accumulation of saturated intramyocellular lipid is associated with insulin resistance[S] (2019) (12)
Insight Into Molecular Determinants of T3 vs T4 Recognition From Mutations in Thyroid Hormone Receptor α and β (2019) (12)
Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide (2019) (12)
Thyroid Hormone Resistance (1999) (11)
Augmentation index in resistance to thyroid hormone (RTH) (2009) (11)
Neonatal thyrotoxicosis and maternal infertility in thyroid hormone resistance due to a mutation in the TRβ gene (M313T) (2002) (10)
Familial dysalbuminaemic hyperthyroxinaemia interferes with current free thyroid hormone immunoassay methods (2020) (10)
Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone. (1999) (9)
Liothyronine cost and prescriptions in England. (2019) (9)
Identification and characterization of a novel de novo mutation (L346V) in the thyroid hormone receptor beta gene in a family with generalized thyroid hormone resistance. (1997) (9)
Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management (2017) (9)
Three Novel Mutations at Serine 314 in the Thyroid Hormone β Receptor Differentially Impair Ligand Binding in the Syndrome of Resistance to Thyroid Hormone1. (1999) (9)
Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance. (2001) (9)
Thyroid gland: TSHR mutations and subclinical congenital hypothyroidism (2015) (8)
Human Genetic Disorders Resulting in Systemic Selenoprotein Deficiency (2021) (8)
Mutations in Humans That Adversely Affect the Selenoprotein Synthesis Pathway (2016) (8)
Chromatin Remodeling by the Thyroid Hormone Receptor in Regulation of the Thyroid-stimulating Hormone α-Subunit Promoter* (2001) (8)
[Thyroid hormone resistance: variable clinical manifestations in five patients]. (1997) (8)
Homozygous Resistance to Thyroid Hormone β: Can Combined Antithyroid Drug and Triiodothyroacetic Acid Treatment Prevent Cardiac Failure? (2017) (8)
Identification of Genetic Disorders Causing Disruption of Selenoprotein Biosynthesis. (2018) (7)
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11th 1993, Cambridge, U.K. (1994) (7)
Fatty Acid Metabolism in Patients with PPAR Mutations (2008) (6)
Nomenclature of thyroid hormone receptor ß gene mutations in resistance to thyroid hormone First Workshop on Thyroid Hormone Resistance, July 10–11, 1993, Cambridge, U.K. (1994) (6)
Hormone-nuclear receptor interactions in health and disease. Thyroid hormone resistance. (1994) (6)
A LONGER TERM TRIAL OF DHEA REPLACEMENT IN ADDISON'S DISEASE (2002) (6)
Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi (2021) (6)
Liver X receptor inhibition potentiates mitotane induced adrenotoxicity in ACC. (2020) (6)
Functional properties of human thyroid hormone receptor β1 overexpressed using baculovirus (1991) (5)
Metyrapone interference in serum cortisol immunoassay (2010) (5)
Nuclear receptors and human disease: resistance to thyroid hormone and lipodystrophic insulin resistance. (2008) (5)
Edinburgh Research Explorer Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance (2018) (5)
Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study (2021) (5)
Chapter 95 – Resistance to Thyroid Hormone∗ (2016) (5)
Residual adrenal function in autoimmune addison s disease effect of dual therapy with rituximab and depot tetracosactide (2018) (5)
Patients with mutations of the Thyroid hormone beta-receptor show an ADHD-like phenotype for performance monitoring: an electrophysiological study (2020) (4)
Dominant Negative Mutations in Human PPARγ–Novel Insights into Glucose Homeostasis and Blood Pressure Regulation in Man (2000) (4)
Resistance to Thyroid Hormone-emerging definition of a disorder of thyroid 1 hormone action 2 3 (2016) (4)
Genetic disorders of thyroid development, hormone biosynthesis and signalling (2022) (4)
Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β (2021) (4)
Principles of hormone action (2010) (4)
Role of Leucine 341 in Thyroid Hormone Receptor Beta Revealed by a Novel Mutation Causing Thyroid Hormone Resistance. (2018) (4)
Resistance to thyroid hormone--an uncommon cause of thyroxine excess and inappropriate TSH secretion. (1994) (3)
Peroxisome Proliferator-Activated Receptor-γ and Insulin Action: Insights from Human Genetics (2003) (3)
Investigating the genetic architecture of gland-in-situ congenital hypothyroidism by comprehensive screening of eight known causative genes (2015) (3)
Fatty Acid Metabolism in Patients with PPAR gamma Mutations (2008) (2)
Response to Letter to the Editor: "Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features". (2019) (2)
Molecular genetics and pathophysiology of thyroid hormone resistance (1997) (2)
1 2 Nuclear receptors and human disease : thyroid receptor , peroxisome-proliferator-activated receptor and orphan receptors (2004) (2)
Fixed drug eruption in the endocrine clinic: rare presentation of reaction to carbimazole (2012) (2)
A natural transactivation mutation in the thyroid hormone b receptor: Impaired interaction with putative transcriptional mediators (resistance to thyroid hormoneyhormone-dependent transactivationycoactivator) (1997) (2)
High‐dose biotin in infants mimics biochemical hyperthyroidism with some commercial assays (2018) (2)
Structure-Guided Approach to Relieving Transcriptional Repression in Resistance to Thyroid Hormone α (2021) (2)
Intrafamilial Phenotypic Variability and Consequences of Non-Compliance with Treatment in Congenital Adrenal Hyperplasia and Congenital Hypothyroidism within a Single Family  (2017) (2)
Clonal Dynamics of Normal Haematopoiesis with Human Ageing (2021) (1)
Reduced pituitary size in subjects with mutations in the THRB gene and thyroid hormone resistance (2021) (1)
Hyperthyroxinemia and Hypercortisolemia due to Familial Dysalbuminemia (2020) (1)
Role of leucine 341 in thyroid hormone receptor β revealed by a novel mutation causing 1 thyroid hormone resistance 2 (2019) (1)
Endocrinopathies are a frequent Consequence of Immune Checkpoint Inhibitor Therapy, with a Low Recovery Rate of both Thyroid and Pituitary Dysfunction (2017) (1)
Chapter 105 – Adrenarche and Adrenopause (2016) (1)
Thyroid hormone pattern in Familial Dysalbuminemic Hyperthyroxinemia (R218H mutation) on different assay platforms (2018) (1)
Erratum: A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia (Journal of Clinical Endocrinology and Metabolism (2014) 99 (E1381-E1386) DOI: 10.1210/jc.2013-4077) (2015) (1)
Low-frequency variation in TP53 has large effects on head circumference and intracranial volume (2019) (1)
Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease (2020) (1)
Thyroid in 2012: Advances in thyroid development, hormone action and neoplasia (2013) (1)
Rheumatoid Factor interference in TSH assays (2012) (1)
A case of undiagnosed multiple endocrine neoplasia type 2B (MEN 2B) (2004) (1)
Transcriptional repression by nuclear receptors: mechanisms and role in disease (2000) (1)
Long term follow up following focused parathyroidectomy for primary hyperparathyroidism (2007) (0)
A role for 11 C-methionine PET/CT-MRI in the management of de novo and residual acromegaly (2015) (0)
Primary hyperparathyroidism in pregnancy-an increasingly common condition? (2007) (0)
Molecular mechanisms underlying action of triac in resistance to thyroid hormone BETA (RTH[beta]) (2022) (0)
Loss-of-function mutations in the immunoglobulin superfamily member 1 gene (IGSF1) cause a novel, X-linked syndrome of central hypothyroidism and testicular enlargement (2013) (0)
A kindred with Carney Complex due to a novel PRKAR1A gene mutation (c1067_1070 del AACG ins GCCCA) (2006) (0)
Insulin receptoropathies are distinguished from other syndromes of severe insulin resistance by elevated plasma adiponectin levels (2006) (0)
Identification of a THRA Mutation in a 2yr Old Child with Clinical Features of Hypothyroidism and Multisystem Involvement (2019) (0)
Severe 21-hydroxylase deficiency congenital adrenal hyperplasia and congenital hypothyroidism due to thyroglobulin mutations in a single family: two distinct genetic disorders with phenotypic variability within a single family (2013) (0)
Congenital Hypothyroidism But Not Athyreosis A Novel Missense Mutation in Human TTF-2 ( FKHL 15 ) Gene Associated with Society (2006) (0)
A Digenic Basis for Severe Insulin Resistance in a Large Human Kindred (2002) (0)
Disorders of Thyroid Hormone Action: insights into biological processes (2018) (0)
Thyroid - from bench to beside (2015) (0)
Minimally invasive parathyroid surgery with intra-operative PTH measurement: an economical approach to the management of primary hyperparathyroidism (2001) (0)
Maternal isodisomy for a novel human FOXE1 gene mutation in syndromic congenital hypothyroidsim (2008) (0)
A novel PPAR gamma mutation (R357X), associated with partial lipodystrophy, helps define the phenotype of the human PPAR gamma ligand resistance (PLR) syndrome (2003) (0)
Congenital Hypothyroidism But Not Athyreosis A Novel Missense Mutation in Human TTF-2 (FKHL15) Gene Associated with (2006) (0)
Novel Insights into Thyroid Hormone Resistance (2014) (0)
Hyperthyroxinaemia with non-suppressed TSH in a clinically euthyroid woman with an unusual sella mass (2009) (0)
Resistance to thyroid hormone alpha: molecular, biochemical and physiological approach to diagnosis and therapy (2022) (0)
Magnetic resonance spectroscopy analysis of intramyocellular lipid composition in lipodystrophic patients and athletes (2018) (0)
Peroxisome proliferator-activated receptor-gamma and insulin action: insights from human genetics. (2003) (0)
Human thyroid hormone receptor alpha mutations [ndash] a novel syndrome emerges (2013) (0)
Syndromes of Resistance to Thyroid Hormone (2021) (0)
Endocrine 01–06 (2003) (0)
MicroTSHoma: an emerging clinical entity with 'atypical' biochemical features and often 'normal' imaging characteristics on MRI (2016) (0)
Dominant-negative mutations in PPAR alpha are present in unselected human populations and have a metabolic signature (2018) (0)
Central hypothyroidism with extrathyroidal features due to a partial X-chromosome deletion involving the TBL1X locus (2017) (0)
SUN-546 Coexistent Resistance to Thyroid Hormone Beta and Viral Thyroiditis (2019) (0)
Good Correlation and Concordance with the Pct Assay on the Brahms Familial Dysalbuminemic Hyperthyroxinemia: a Persistent Diagnostic Challenge Letters to the Editor (2009) (0)
Molecular spectrum of TSHb subunit gene defects in central hypothyroidism in the UK and Ireland (2017) (0)
Rates of maternal complications from TRAb positive pregnancies are low, but strongly positive TRAb in later pregnancy is associated with adverse neonatal outcomes (2019) (0)
The steroid hormone superfamily of receptors (2020) (0)
Thiazolidinediones and PGJ(2) have depot-specific effects on human pre-adipocyte differentiation. (1997) (0)
British Thyroid Association Pitt-Rivers Lecture (2014) (0)
The challenges to diagnose and differentiate TSHoma from thyroid hormone resistance: a case report (2016) (0)
Iopanoic acid: a bridge to surgery when all else fails in complicated hyperthyroidism (2010) (0)
G450(P) An uncommon cause of deranged thyroid function in a family line (2016) (0)
The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis (2012) (0)
Introduction of Ambulatory Parathyroid Surgery: A United Kingdom Perspective: [2002][A-1] (2002) (0)
Total versus sub-total thyroidectomy for Grave’s disease [Protocol] (2013) (0)
Peroxisome proliferator-activated receptor γ—insights from human genetics (2004) (0)
The role of in vivo metabolomics using H-MRS in SDH deficient disease (2017) (0)
Insight Into Molecular Determinants of T 3 vs T 4 Recognition From Mutations in Thyroid Hormone Receptor a and b (2019) (0)
Molecular Pathogenesis of Resistance to Thyroid Hormone (2004) (0)
A novel, missense, mutation (P81R) in the TRH receptor gene in congenital central hypothyroidism (2015) (0)
Familial dysalbuminaemic hyperthyroxinaemia: a persistent diagnostic problem (2008) (0)
Neurocognitive and CNS abnormalities in humans with defective thyroid receptor [alpha] (2014) (0)
Congenital central hypothyroidism due to a TSHB mutation with uniparental inheritance (2014) (0)
Non-autoimmune thyroid disease (2002) (0)
A digenic basis for severe insulin resistance in a large UK kindred - cosegregation of mutations in PPAR gamma and PPP1R3 (2002) (0)
An audit of radioiodine treatment for thyrotoxicosis in Cambridge (2006) (0)
Molecular Biology of Thyroid Hormone Action (1997) (0)
Unusual or Perplexing Thyroid Cases (2013) (0)
Three Novel Mutations at Serine 314 in the Thyroid Hormone b Receptor Differentially Impair Ligand Binding in the Syndrome of Resistance to Thyroid Hormone* (1999) (0)
Clinical management and outcomes of anti-TSH receptor antibody positive pregnancies (2010) (0)
Weight gain, on the background of human PPAR[gamma] haploinsufficiency, exposes a metabolic phenotype (2008) (0)
Metastatic insulinoma or not (2006) (0)
An unusual case of a disappearing TSHoma (2009) (0)
False positive newborn screen for congenital hypothyroidism due to a TSH-IgG (macro-TSH) complex (2006) (0)
An audit of long-acting Somatostatin receptor ligand therapy in acromegaly (2004) (0)
Poster presentations (Thursday) (2008) (0)
Metastatic insulinoma with persistent hypoglycaemia (2009) (0)
Targeted RNA interference to selectively modulate expression of PPARgamma2 and 1 isoforms (2004) (0)
Review of patients with adrenocortical carcinoma at a tertiary referral centre (2013) (0)
PPAR gamma and human insulin resistance (2001) (0)
The challenge of managing refractory amiodarone-induced Graves' disease in resistance to thyroid hormone (2013) (0)
A multisystem disorder associated with defective selenoprotein synthesis and a thyroid signature (2009) (0)
Adult growth hormone replacement therapy after the institution of NICE guidelines (2006) (0)
Graves' disease with fluctuating thyroid status and hypothyroidism with positive anti-TSH receptor antibody levels - distinctive autoimmune side-effects following alemtuzumab therapy for multiple sclerosis (2016) (0)
Discordant TSH measurements in an euthyroid child due to a homozygous TSHbeta subunit gene variant with variable immunoreactivity (2017) (0)
Autoimmune thyroid disease in the presence of resistance to thyroid hormone or TSH-secreting pituitary tumour: a diagnostic challenge (2014) (0)
Hormone action: Insights from human genetic disorders (2006) (0)
1SY01-2 PPARγ- Insights from human genetics (2003) (0)
Evaluation of fine needle aspiration and ultrasound in diagnostic assessment of thyroid nodules (2013) (0)
DIre Straits - hypothalamic diabetes insipidus, acute myeloid leukaemia and high risk cytogenetics: 45,XX,t(3;3)(q21q26),-7 (2006) (0)
Generalised resistance to thyroid hormone secondary to a novel heterozygous missense mutation with coincidental toxic nodular goitre (2009) (0)
Molecular Characterisation of Dominant Negative Mutations in Human Pparγ (2002) (0)
Homozygous resistance to thyroid hormone: can cardiac complications be prevented? (2013) (0)
Insight into molecular determinants of T 3 vs . T 4 recognition from mutations in thyroid 1 hormone receptor alpha and beta 2 3 (2019) (0)
Transcriptional interference by novel human PPARgamma mutants associated with lipodystrophic insulin resistance (2004) (0)
UK 10 K Consortium (2019) (0)
Central arterial stiffness in resistance to thyroid hormone (2007) (0)
11C-methionine PET[ndash]CT co-registered with volume MRI identifies residual functioning tumour in acromegaly (2013) (0)
Mutations in SECISBP2 (2015) (0)
11C-methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas (2014) (0)
Front & Back Matter (2012) (0)
Anemia in PatientsWithResistance to ThyroidHormone a : A Role for Thyroid Hormone Receptor a in Human Erythropoiesis (2017) (0)
A multisystem selenoprotein disorder with a thyroid signature (2010) (0)
Sleep disorders and response to treatment in the Acromegalic cardiovascular and respiratory outcomes with primary analogue therapy (ACROPAT) trial (2007) (0)
Liothyronine prescribing in the UK has changed dramatically with widespread variation by clinical commissioning group and is strongly influenced by economic deprivation (2018) (0)
The effect of somatostatin analogues on the hypothalamo-pituitary-thyroid axis and peripheral thyroid hormone dependent tissues in patients with thyrotropin secreting pituitary tumours (2014) (0)
Thyrotropinoma: diagnosis and management of a rare but increasingly recognised pituitary tumour - novel insights from a large prospective UK study (2015) (0)
Selenoprotein deficiency disorder predisposes to aortic aneurysm formation (2022) (0)
Potential pitfalls in the management of thyrotropinoma (2012) (0)
Centile reference chart for resting metabolic rate through the life course (2023) (0)
Meeting abstracts from the 64th British Thyroid Association Annual Meeting (2017) (0)
Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor [alpha] mutation (2012) (0)
Nuclear receptors and human disease: thyroid receptor , peroxisome-proliferator- activated receptorand orphan receptors (2004) (0)
Sclerosing Hashimoto's thyroiditis: a case presentation (2011) (0)
Clinical, metabolic, biochemical and radiological characterisation of patients with thyrotropinomas reveals a highly variable phenotype (2013) (0)
Compensated hyperthyrotropinaemia due to partial loss-of-function mutation in TSH receptor gene (2017) (0)
Resistance to thyroid hormone and PPARy resistance (2001) (0)
Resistance to Thyroid Hormone Syndrome from Childhood to Adulthood: Variation in Symptoms and Thyroid Function (2014) (0)
Disorders of thyroid hormone action: insights from human genetics (2014) (0)
A Girl with Goiter and Inappropriate Thyroid-Stimulating Hormone Secretion (2008) (0)
Phenotype of mice harboring a thyroid hormone receptor alpha 1 gene with transdominant negative properties (2001) (0)
Depot somatostatin receptor ligand therapy reverses tissue thyrotoxicosis in thyrotropinomas and aids microadenoma localization via 11C-Methionine PET (2022) (0)
Hiding in plain sight: A case of severe refractory primary hyperparathyroidism due to an intrathyroidal ectopic parathyroid adenoma (2020) (0)
Nutrient receptors in diabetes and the metabolic syndrome (2004) (0)
Iopanoic acid safely, quickly and effectively induces euthyroidism in resistant thyrotoxicosis (2019) (0)
Severe hyponatremia and subsequent extra-pontine myelinolysis as a presentation of addisons disease (2006) (0)
Weird thyroid function tests (2011) (0)
Universitet Low-frequency variation in TP 53 has large effects on head circumference and intracranial (2019) (0)
Cardiovascular impact of thyroid hormone receptor mutations (2015) (0)
Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial (2020) (0)
Thyroid development--revisiting a foxeing case. (2009) (0)
Total thyroidectomy versus subtotal thyroidectomy for Graves' disease (2013) (0)
CMF01 – Unusual or Perplexing Thyroid Cases (2013) (0)
Ectopic ACTH-management difficulties (2007) (0)

This paper list is powered by the following services:

Other Resources About Krishna Chatterjee

en.wikipedia.org

What Schools Are Affiliated With Krishna Chatterjee?

Krishna Chatterjee is affiliated with the following schools:

Krishna Chatterjee's Academic­Influence.com Rankings